Metacrine, Inc.
NASDAQ: MTCR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David M. Maggio
- Employees
- 10
- Headquarters
- San Diego, United States
- IPO year
- 2020
- Website
- https://www.metacrine.com
Loading MTCR…
Loading profile data…Frequently asked questions about MTCR
What does Metacrine, Inc. (MTCR) do?
Metacrine, Inc., established in 2014 and operating from its headquarters in San Diego, California, is a clinical-stage biopharmaceutical company. The firm's core mission involves identifying and advancing novel therapies specifically designed for patients suffering from gastrointestinal disorders. Among its developmental pipeline, Metacrine is p...
Where does MTCR trade?
Metacrine, Inc. (MTCR) trades on the NASDAQ Capital Market.
What sector is MTCR in?
Metacrine, Inc. (MTCR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Metacrine, Inc.?
David M. Maggio is the chief executive officer of Metacrine, Inc. (MTCR).
Where is Metacrine, Inc. headquartered?
Metacrine, Inc. is headquartered in United States.
Does MTCR pay a dividend?
Metacrine, Inc. (MTCR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MTCR go public?
Metacrine, Inc. (MTCR) completed its initial public offering in 2020.